{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:55:59Z","timestamp":1649102159034},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/wnf.0000000000000018","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T13:07:11Z","timestamp":1394456831000},"page":"45-51","source":"Crossref","is-referenced-by-count":3,"title":["Benefit of Additional Screening for Progressive Multifocal Leukoencephalopathy in Patients With Multiple Sclerosis Taking Natalizumab"],"prefix":"10.1097","volume":"37","author":[{"given":"David C.","family":"Landy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/practneurol-2011-000092","article-title":"Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring.","volume":"12","year":"2012","journal-title":"Pract Neurol"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0b013e318245d2d0","article-title":"Risk stratification and patient counseling for natalizumab in multiple sclerosis.","volume":"78","year":"2012","journal-title":"Neurology"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"s6","DOI":"10.1002\/ana.410360704","article-title":"The natural history of multiple sclerosis.","volume":"36","year":"1994","journal-title":"Ann Neurol"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/00023210-200822100-00004","article-title":"Health-related quality of life in multiple sclerosis.","volume":"22","year":"2008","journal-title":"CNS Drugs"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:09:35Z","timestamp":1620976175000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201403000-00002"}},"subtitle":["A Decision Analysis"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000018","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}